1. Murphy, F.A.; Gibbs, E. P.J.; Horzinek, M. C. and Studdert, M.J. (1999): Veterinary Virology, Third Edition. Copyright by Academic Press.
2. Burgess GW and Spradbrow PB (1977): Studies on the pathogenesis of bovine ephemeral fever. Aust Vet J., 53: 363-368. Doi: 10.1111/j. 1751 0813.1977.tb07952.x. PubMed: 337960.
3. Walker PJ (2005): Bovine ephemeral fever in Australia and the world. Curr Top Microbiol Immunol, 292: 57-80. PubMed: 15981468.
4. Sewell, M.M.A. and Brocklesby,B.R (1990): Handbock of Animal Disease in the Tropics, 4th Edition, Bailliere Tindall, London.
5. Fearon, D.T., (1997): Seeking wisdom in innate immunity. Nature, 388 (6640):323-324.
6. Bomford, R.., (1998): Will adjuvants be needed for vaccines of the future? In: Brown, F., Haaheim, L.R. (Eds.), Modulation of the Immune Response to Vaccine Antigens, Vol. 92. Development in Biological Standardization, Basel, Karger, p.13-17.
7. Carbomer 934P. USP XXII, NF XVII. United States Pharmacopeial Convention Inc., Rockville, Maryland, 1990: 1911.
8- Oda, K., Matsuda, H., Murakami, T., Katayama, S., Ohgitani, T and Yoshikawa, M., (2000): Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants. Biol. Chem., 381(1):67-74.
9. Jie, Y.H., Cammisuli, S.,and Baggliolini, M., (1984): Immunomodulatory effects of Panax ginseng CA Meyer in the mouse. Agents Actions, 15 (3-4):386-391.
10. Kensil, C.R., (1996). Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carrier Syst., 13(1-2):1-55.
11. Soad, M. Soliman; Taha, M.M.; Samir, S.S. and Daoud, A. M. (2001): Isolation and identification of BEF virus in Egypt, Beni-Suef Vet. J. Vol. XI. No. (2), 24-32.
12. Azab, A. M, Khodeir, M.H.; Attyat, M. Kotb and El- Gallad, S. B. Kh. (2002): Susceptibility of different cell culture to bovine ephemeral virus. 6thVet. Med. Conf. Hurghada; 41-55.
13. Al-Behwar, A.M.; Nermein, G. Shafeik; Saad, M.A.; Ibrahim, M.M.; Magda, S. Mohamed; Anhar Abd El-Moety and Khodeir, M.H. (2010): Comparative evaluation of the potency of traditionally inactivated bovine ephemeral fever vaccine and that one inactivated on the time of vaccination. 14th Sci.Cong. Fac. Vet. Med. Assiut Univ., Egypt; 51-61.
14. Macpherson, I.A. and Stocker, M.G.P. (1962): Polyoma transformation of hamster cell clones: an investigation of genetic factors affecting cell competence Virology, 16:147.
15. Amoros, M.; Fauconnier, B. and Girre, R.L. (1987): In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus. Antiviral Research, Vol.8, Issue 1, 13-25.
16- Code of Federal Regulation of USA, (1986): Published by the Office of the Federal Register National Archives and Record Administration. Animal and Animal products.
17. Rossiter, P.B.; Jessett, D.M. and Taylor, W.P.(1985): Microneutralization system for use with different strains of peste des petits ruminant's virus. Top. Anim. Hith. Prod., 17(2): 75-81.
18-Wagner, G.G., Card, J.L.,and Cowan, K.M., (1969): Plum Island Animal Disease Laboratory, Animal Disease and Parasite Research Division Agricultural Research Service. Department of Agricultural, Greanport, New York, USA.
19- Zakrzewski, H., Cybinski, D.H.,and Walker, P.J.(1992): A blocking ELISA for the detection of specific antibodies to bovine ephemeral fever virus. J. Immunol. Methods, 151, 289-297.
20- de Oliveira, C.A.C., Perez, A.C., Merino, G., Prieto, J.G.,and Alvarez, A.I., (2001): Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise.Comp. Biochem. Physiol., 130(3):369-377.
21- Haridas, V., Arntzen, C.J.,and Gutterman, J.U., (2001): Avicins, a family of triterpenoid saponins from Acacia victoria (Bentham), inhibit activation of nuclear factor-kappa B by inhibiting both its nuclear localization and ability tobind DNA. Proc. Natl. Acad. Sci. USA, 98(20):11557-11562.
22- Delmas, F., Di Giorgio, C., Elias, R., Gasquet, M., Azas, N.,Mshvildadze, V., Dekanosidze, G., Kemertelidze, E.,and Timon-David, P., (2000): Antileishmanial activity of three saponins isolated from ivy, alpha-hederin, beta-hederin and hederacolchiside A(1), as compared with their action on mammalian cells cultured in vitro. Planta Medica, 66(4):343-347.
23-Yui, S., Ubukata, K., Hodono, K., Kitahara, M., Mimaki, Y., Kuroda, M., Sashida, Y., and Yamazaki, M., (2001): Macrophage-oriented cytotoxic activity of novel triterpene saponins extracted from roots of Securidaca inappendiculata. Int. Immunopharmacol., 1(11):1989-2000.
24-Duk Kyung Kim,A Hyun S. Lillehoj,AD Sung Hyen Lee,A Paul Dominowski,B Robert J. Yancey,B and Erik P. Lilleho (2012): Effects of Novel Vaccine/Adjuvant Complexes on the Protective Immunity AgainstEimeria acervulina and Transcriptome Profiles. Avian Diseases, 56:97–109, 2012
25- Krashias G, Simon AK, Wegmann F, Kok WL, Ho LP ,and Stevens D, (2010): Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer. Vaccine, 28(13):2482–2489.
26- Gartlana, , George Krashiasa, Frank Wegmanna,1, William R. Hillsona,Erin M. Schererb, Philip D. Greenbergb, Stephanie C. Eisenbarthc, Amin E. Moghaddama, and Quentin J. Sattentauaa Sir (2016): Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns Kate H Vaccine 34 2188–2196
27-Diamantstein T, Wagner B, Beyse I, Odenwald MV, and Schulz G. (1971): Stimulation of humoral antibody formation by polyanions: I. The effect of polyacrylic acid on the primary immune response in mice immunized with sheep red blood cells. Eur J Immunol, 1:335–40.
28- Gall D, Knight PA, and Hampson F. (1972): Adjuvant activity of polyelectrolytes. Immunology; 23:569–75.
29- Gualandi GL, Losio NM, Muratori G, and Foni E. (1988): The ability by different preparations of porcine parvovirus to enhance humoral immunity in swine and guinea pigs. Microbiologica, 11:363–9.
30- Tollersrud T, Norstebo PE, Engvik JP, Andersen SR, Reitan LJ, and Lund A (2002): Antibody responses in sheep vaccinated against Staphylococcus aureus mastitis: a comparison of two experimental vaccines containing different adjuvants. Vet Res Commun, 26:587–600.
31- Lai RP, Seaman MS, Tonks P, Wegmann F, Seilly DJ, and Frost SD, (2012): Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund’s adjuvants. PLoS ONE 7.
32- Dey AK, Burke B, Sun Y, Hartog K, Heeney JL, and Montefiori D, (2012): Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. Vaccine, 30:2749–59.